Video

Dr. Marshall on the Luminary Awards in GI Cancers

John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the first annual Luminary Awards in GI Cancers, which is honoring five individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers.

John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the first annual Luminary Awards in GI Cancers, which is honoring five individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers.

The five honorees are:

  • Julie Fleshman, JD, MBA Pancreatic Cancer Action Network
  • Daniel G. Haller, MD, FACP, FRCP - Abramson Cancer Center, University of Pennsylvania
  • Henry T. Lynch, MD, MS, FACP, FAACR - Creighton University School of Medicine
  • Frank McCormick, PhD, FRS - University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
  • Andrew L. Warshaw, MD, FACS, FRCSED (HON) - Harvard Medical School, Massachusetts General Hospital

https://www.onclive.com/luminary-awards

The event will take place at 6 pm on December 1 at The St. Regis Washington DC in Washington, DC. Those who are interested can sign up to attend at .

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS